ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dolutegravir Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-13A9750
Home | Market Reports | Health| Pharmacy
Global Dolutegravir Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dolutegravir Market Research Report 2025

Code: QYRE-Auto-13A9750
Report
September 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan NV
Aurobindo Pharma
Laurus Labs
Adcock Ingram Limited

Dolutegravir Market

The global market for Dolutegravir was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Dolutegravir is an antiviral medication used, together with other medication, to treat HIV/AIDS. It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure. It is a type of integrase inhibitor, which blocks the action of the integrase enzyme, which is involved in viral replication. This helps to reduce the amount of virus in the body and may help to improve symptoms. Dolutegravir is taken as a tablet once daily, with or without food.
The future market trends of Dolutegravir are expected to be influenced by the following factors:The increasing incidence of HIV/AIDS, rising demand for better treatment options, and the growing number of approvals for Dolutegravir.The introduction of new drugs and formulations that may offer better efficacy and safety than Dolutegravir, such as long-acting injectable formulations, dual therapies, and novel integrase inhibitors.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Dolutegravir has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of HIV infection and affect the access and adherence to Dolutegravir treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dolutegravir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir.
The Dolutegravir market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dolutegravir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dolutegravir Market Report

Report Metric Details
Report Name Dolutegravir Market
Segment by Type
  • 10mg Tablets
  • 50mg Tablets
Segment by Application
  • Prevent HIV Infection Following Potential Exposure
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs, Adcock Ingram Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dolutegravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dolutegravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dolutegravir Market report?

Ans: The main players in the Dolutegravir Market are ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs, Adcock Ingram Limited

What are the Application segmentation covered in the Dolutegravir Market report?

Ans: The Applications covered in the Dolutegravir Market report are Prevent HIV Infection Following Potential Exposure, Others

What are the Type segmentation covered in the Dolutegravir Market report?

Ans: The Types covered in the Dolutegravir Market report are 10mg Tablets, 50mg Tablets

1 Dolutegravir Market Overview
1.1 Product Definition
1.2 Dolutegravir by Type
1.2.1 Global Dolutegravir Market Value Comparison by Type (2024 VS 2031)
1.2.2 10mg Tablets
1.2.3 50mg Tablets
1.3 Dolutegravir by Application
1.3.1 Global Dolutegravir Market Value by Application (2024 VS 2031)
1.3.2 Prevent HIV Infection Following Potential Exposure
1.3.3 Others
1.4 Global Dolutegravir Market Size Estimates and Forecasts
1.4.1 Global Dolutegravir Revenue 2020-2031
1.4.2 Global Dolutegravir Sales 2020-2031
1.4.3 Global Dolutegravir Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dolutegravir Market Competition by Manufacturers
2.1 Global Dolutegravir Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dolutegravir Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dolutegravir Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dolutegravir, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dolutegravir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dolutegravir, Product Type & Application
2.7 Global Key Manufacturers of Dolutegravir, Date of Enter into This Industry
2.8 Global Dolutegravir Market Competitive Situation and Trends
2.8.1 Global Dolutegravir Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dolutegravir Players Market Share by Revenue
2.8.3 Global Dolutegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dolutegravir Market Scenario by Region
3.1 Global Dolutegravir Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dolutegravir Sales by Region: 2020-2031
3.2.1 Global Dolutegravir Sales by Region: 2020-2025
3.2.2 Global Dolutegravir Sales by Region: 2026-2031
3.3 Global Dolutegravir Revenue by Region: 2020-2031
3.3.1 Global Dolutegravir Revenue by Region: 2020-2025
3.3.2 Global Dolutegravir Revenue by Region: 2026-2031
3.4 North America Dolutegravir Market Facts & Figures by Country
3.4.1 North America Dolutegravir Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dolutegravir Sales by Country (2020-2031)
3.4.3 North America Dolutegravir Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dolutegravir Market Facts & Figures by Country
3.5.1 Europe Dolutegravir Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dolutegravir Sales by Country (2020-2031)
3.5.3 Europe Dolutegravir Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dolutegravir Market Facts & Figures by Region
3.6.1 Asia Pacific Dolutegravir Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dolutegravir Sales by Region (2020-2031)
3.6.3 Asia Pacific Dolutegravir Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dolutegravir Market Facts & Figures by Country
3.7.1 Latin America Dolutegravir Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dolutegravir Sales by Country (2020-2031)
3.7.3 Latin America Dolutegravir Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dolutegravir Market Facts & Figures by Country
3.8.1 Middle East and Africa Dolutegravir Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dolutegravir Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dolutegravir Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dolutegravir Sales by Type (2020-2031)
4.1.1 Global Dolutegravir Sales by Type (2020-2025)
4.1.2 Global Dolutegravir Sales by Type (2026-2031)
4.1.3 Global Dolutegravir Sales Market Share by Type (2020-2031)
4.2 Global Dolutegravir Revenue by Type (2020-2031)
4.2.1 Global Dolutegravir Revenue by Type (2020-2025)
4.2.2 Global Dolutegravir Revenue by Type (2026-2031)
4.2.3 Global Dolutegravir Revenue Market Share by Type (2020-2031)
4.3 Global Dolutegravir Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dolutegravir Sales by Application (2020-2031)
5.1.1 Global Dolutegravir Sales by Application (2020-2025)
5.1.2 Global Dolutegravir Sales by Application (2026-2031)
5.1.3 Global Dolutegravir Sales Market Share by Application (2020-2031)
5.2 Global Dolutegravir Revenue by Application (2020-2031)
5.2.1 Global Dolutegravir Revenue by Application (2020-2025)
5.2.2 Global Dolutegravir Revenue by Application (2026-2031)
5.2.3 Global Dolutegravir Revenue Market Share by Application (2020-2031)
5.3 Global Dolutegravir Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ViiV Healthcare (GSK)
6.1.1 ViiV Healthcare (GSK) Company Information
6.1.2 ViiV Healthcare (GSK) Description and Business Overview
6.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ViiV Healthcare (GSK) Dolutegravir Product Portfolio
6.1.5 ViiV Healthcare (GSK) Recent Developments/Updates
6.2 Shanghai Desano Pharmaceuticals
6.2.1 Shanghai Desano Pharmaceuticals Company Information
6.2.2 Shanghai Desano Pharmaceuticals Description and Business Overview
6.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolio
6.2.5 Shanghai Desano Pharmaceuticals Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Dolutegravir Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Dolutegravir Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Company Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aurobindo Pharma Dolutegravir Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 LAURUS Labs
6.5.1 LAURUS Labs Company Information
6.5.2 LAURUS Labs Description and Business Overview
6.5.3 LAURUS Labs Dolutegravir Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LAURUS Labs Dolutegravir Product Portfolio
6.5.5 LAURUS Labs Recent Developments/Updates
6.6 Adcock Ingram Limited
6.6.1 Adcock Ingram Limited Company Information
6.6.2 Adcock Ingram Limited Description and Business Overview
6.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Adcock Ingram Limited Dolutegravir Product Portfolio
6.6.5 Adcock Ingram Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dolutegravir Industry Chain Analysis
7.2 Dolutegravir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dolutegravir Production Mode & Process Analysis
7.4 Dolutegravir Sales and Marketing
7.4.1 Dolutegravir Sales Channels
7.4.2 Dolutegravir Distributors
7.5 Dolutegravir Customer Analysis
8 Dolutegravir Market Dynamics
8.1 Dolutegravir Industry Trends
8.2 Dolutegravir Market Drivers
8.3 Dolutegravir Market Challenges
8.4 Dolutegravir Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan NV
Aurobindo Pharma
Laurus Labs
Adcock Ingram Limited
List of Tables
 Table 1. Global Dolutegravir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dolutegravir Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dolutegravir Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dolutegravir Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Dolutegravir Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dolutegravir Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dolutegravir Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dolutegravir Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dolutegravir, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dolutegravir, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dolutegravir, Product Type & Application
 Table 12. Global Key Manufacturers of Dolutegravir, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dolutegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dolutegravir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dolutegravir Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Dolutegravir Sales Market Share by Region (2020-2025)
 Table 19. Global Dolutegravir Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Dolutegravir Sales Market Share by Region (2026-2031)
 Table 21. Global Dolutegravir Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dolutegravir Revenue Market Share by Region (2020-2025)
 Table 23. Global Dolutegravir Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dolutegravir Revenue Market Share by Region (2026-2031)
 Table 25. North America Dolutegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dolutegravir Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Dolutegravir Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Dolutegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dolutegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dolutegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dolutegravir Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Dolutegravir Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Dolutegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dolutegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dolutegravir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dolutegravir Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Dolutegravir Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Dolutegravir Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dolutegravir Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dolutegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dolutegravir Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Dolutegravir Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Dolutegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dolutegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dolutegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dolutegravir Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Dolutegravir Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Dolutegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dolutegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dolutegravir Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Dolutegravir Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Dolutegravir Sales Market Share by Type (2020-2025)
 Table 53. Global Dolutegravir Sales Market Share by Type (2026-2031)
 Table 54. Global Dolutegravir Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dolutegravir Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dolutegravir Revenue Market Share by Type (2020-2025)
 Table 57. Global Dolutegravir Revenue Market Share by Type (2026-2031)
 Table 58. Global Dolutegravir Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Dolutegravir Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Dolutegravir Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Dolutegravir Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Dolutegravir Sales Market Share by Application (2020-2025)
 Table 63. Global Dolutegravir Sales Market Share by Application (2026-2031)
 Table 64. Global Dolutegravir Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dolutegravir Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dolutegravir Revenue Market Share by Application (2020-2025)
 Table 67. Global Dolutegravir Revenue Market Share by Application (2026-2031)
 Table 68. Global Dolutegravir Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Dolutegravir Price (USD/Pcs) by Application (2026-2031)
 Table 70. ViiV Healthcare (GSK) Company Information
 Table 71. ViiV Healthcare (GSK) Description and Business Overview
 Table 72. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. ViiV Healthcare (GSK) Dolutegravir Product
 Table 74. ViiV Healthcare (GSK) Recent Developments/Updates
 Table 75. Shanghai Desano Pharmaceuticals Company Information
 Table 76. Shanghai Desano Pharmaceuticals Description and Business Overview
 Table 77. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Shanghai Desano Pharmaceuticals Dolutegravir Product
 Table 79. Shanghai Desano Pharmaceuticals Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Mylan Dolutegravir Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Aurobindo Pharma Company Information
 Table 86. Aurobindo Pharma Description and Business Overview
 Table 87. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Aurobindo Pharma Dolutegravir Product
 Table 89. Aurobindo Pharma Recent Developments/Updates
 Table 90. LAURUS Labs Company Information
 Table 91. LAURUS Labs Description and Business Overview
 Table 92. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. LAURUS Labs Dolutegravir Product
 Table 94. LAURUS Labs Recent Developments/Updates
 Table 95. Adcock Ingram Limited Company Information
 Table 96. Adcock Ingram Limited Description and Business Overview
 Table 97. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Adcock Ingram Limited Dolutegravir Product
 Table 99. Adcock Ingram Limited Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Dolutegravir Distributors List
 Table 103. Dolutegravir Customers List
 Table 104. Dolutegravir Market Trends
 Table 105. Dolutegravir Market Drivers
 Table 106. Dolutegravir Market Challenges
 Table 107. Dolutegravir Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dolutegravir
 Figure 2. Global Dolutegravir Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dolutegravir Market Share by Type: 2024 & 2031
 Figure 4. 10mg Tablets Product Picture
 Figure 5. 50mg Tablets Product Picture
 Figure 6. Global Dolutegravir Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dolutegravir Market Share by Application: 2024 & 2031
 Figure 8. Prevent HIV Infection Following Potential Exposure
 Figure 9. Others
 Figure 10. Global Dolutegravir Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Dolutegravir Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Dolutegravir Sales (2020-2031) & (K Pcs)
 Figure 13. Global Dolutegravir Average Price (USD/Pcs) & (2020-2031)
 Figure 14. Dolutegravir Report Years Considered
 Figure 15. Dolutegravir Sales Share by Manufacturers in 2024
 Figure 16. Global Dolutegravir Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Dolutegravir Players: Market Share by Revenue in Dolutegravir in 2024
 Figure 18. Dolutegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Dolutegravir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Dolutegravir Sales Market Share by Country (2020-2031)
 Figure 21. North America Dolutegravir Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Dolutegravir Sales Market Share by Country (2020-2031)
 Figure 25. Europe Dolutegravir Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Dolutegravir Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Dolutegravir Revenue Market Share by Region (2020-2031)
 Figure 33. China Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Dolutegravir Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Dolutegravir Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Dolutegravir Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Dolutegravir Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Dolutegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Dolutegravir by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Dolutegravir by Type (2020-2031)
 Figure 55. Global Dolutegravir Price (USD/Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Dolutegravir by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Dolutegravir by Application (2020-2031)
 Figure 58. Global Dolutegravir Price (USD/Pcs) by Application (2020-2031)
 Figure 59. Dolutegravir Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Dolutegravir Sodium Market Research Report 2024
Global Dolutegravir and Dolutegravir Generic Drug Market Research Report 2025
Global Dolutegravir and Its Combination Drug Market Research Report 2024
Global Dolutegravir Rilpivirine Combination Drug Market Research Report 2024
Global Glecaprevir Market Research Report 2025
Global Daclatasvir Market Research Report 2024
Global Elvitegravir Combination Drugs Market Research Report 2024
Global Velpatasvir Market Research Report 2025
Grazoprevir Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dolutegravir Intermediates Market Research Report 2024
Global Raltegravir API Market Research Report 2025
Global Avelumab Market Research Report 2024
Global Guava Market Research Report 2024
Global Nirmatrelvir API Market Research Report 2025
Global Guadecitabine Market Research Report 2025
Global Brivudine Market Research Report 2025
Global Lamivudine and Zidovudine Market Research Report 2024
Sofosbuvir Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Retroviral Drugs Market Research Report 2024
Global Human Immunodeficiency Virus Type 1 Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions